Enteric microflora in inflammatory bowel disease patients;Microbiote intestinal et développement des maladies inflammatoires chroniques de l'intestin

Medecine/Sciences

Volumn 32, Issue 11, 2016, Pages 968-973

  Rahmouni, Oumaira ^a   Dubuquoy, Laurent ^a   Desreumaux, Pierre ^a   Neut, Christel ^a  

^a UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECTS; ANIMAL; BACTERIAL INFECTION; COMPLICATION; DIET; DYSBIOSIS; GASTROENTERITIS; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; BACTERIAL INFECTIONS; DIET; DYSBIOSIS; GASTROENTERITIS; GASTROINTESTINAL MICROBIOME; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 85008319921     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/20163211012     Document Type: Review

References (28)

1. Nitzan O, Elias M, Peretz A, et al. Role of antibiotics for treatment of inflammatory bowel disease. World J Gastroenterol 2016; 22: 1078-87.
2. Dutta AK, Chacko A. Influence of environmental factors on the onset and course of inflammatory bowel disease. World J Gastroenterol 2016; 22: 1088-100.
3. Molodecky NA, Kaplan GG. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol 2010; 6: 339-46.
4. Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol 2015; 12: 205-17.
5. Sartor RB, Mazmanian SK. Intestinal microbes in inflammatory bowel diseases. Am J Gastroenterol 2012; 1 (suppl): 15-21.
6. Morgan XC, Tickle TL, Sokol H, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 2012; 13: 1-18.
7. Comito D, Cascio A, Romano C. Microbiota biodiversity in inflammatory bowel disease. Ital J Pediatr 2014; 40: 1-6.
8. Leone V, Chang EB, Devkota S. Diet, microbes, and host genetics: the perfect storm in inflammatory bowel diseases. J Gastroenterol 2013; 48: 315-21.
9. Serban DE. Microbiota in inflammatory bowel disease pathogenesis and therapy: is it all about diet? Nutr Clin Pract 2015; 30: 760-79.
10. Neuman MG, Nanau RM. Inflammatory bowel disease: role of diet, microbiota, life style. Transl Res 2012; 160: 29-44.
11. Dalal SR, Chang EB. The microbial basis of inflammatory bowel diseases. J Clin Invest 2014; 124: 4190-96.
12. Jess T, Simonsen J, Nielsen NM, et al. Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease. Gut 2011; 60: 318-24.
13. Rodríguez LAG, Ruigómez A, Panés J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 2006; 130: 1588-94.
14. Baumgart DC, Sandborn WJ. Crohn's disease. Lancet 2012; 380: 1590-605.
15. Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics and new diagnoses of crohn's disease and ulcerative colitis. Am J Gastroenterol 2011; 106: 2133-42.
16. Standaert-Vitse A, Sendid B, Joossens M, et al. Candida albicans colonization and ASCA in familial Crohn's disease. Am J Gastroenterol 2009; 104: 1745-53.
17. Standaert-Vitse A, Jouault T, Vandewalle P, et al. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of crohn's disease. Gastroenterology 2006; 130: 1764-75.
18. Schuppler M, Loessner MJ. The opportunistic pathogen Listeria monocytogenes: pathogenicity and interaction with the mucosal immune system. Int J Inflam 2010; 2010: 1-12.
19. Tamboli CP, Neut C, Desreumaux P, et al. Dysbiosis in inflammatory bowel disease. Gut 2004; 53: 1-4.
20. Drouet M, Vignal C, Singer E, et al. AIEC colonization and pathogenicity: influence of previous antibiotic treatment and preexisting inflammation. Inflamm Bowel Dis 2012; 18: 1923-31.
21. Sears CL. Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes, Clin Microbiol Rev 2009; 22: 349-69.
22. Small CL, Reid-Yu SA, McPhee JB, et al. Persistent infection with Crohn's disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis. Nat Common 2013; 4: 1-19.
23. Chassaing B, Darfeuille-Michaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011; 140: 1720-8.
24. Torres J, Burisch J, Riddle M, et al. Preclinical disease and preventive strategies in IBD: perspectives, challenges and opportunities. Gut 2016; 65: 1061-9.
25. Burcelin R, Nicolas S, Blasco-Baque V. Microbiotes et maladies métaboliques: de nouveaux concepts pour de nouvelles stratégies thérapeutiques. Med Sci (Paris) 2016; 32: 952-60.
26. Gaboriau-Routhiau V, Cerf-Bensussan N. Microbiote intestinal et développement du système immunitaire. Med Sci (Paris) 2016; 32: 961-7.
27. Stetdman A, Nigro G, Sansonetti P. Le dialogue microbiote-cellules souches: un élément clé pour la régénération intestinale. Med Sci (Paris) 2016; 32: 983-90.
28. Sendid B, Jouault T, Vitse A. Glycannes pariétaux de levures et anticorps spécifiques. Med Sci (Paris) 2009; 25: 473-82.